Search

Mounting studies have highlighted the pivotal influence of anti-silencing function 1B (ASF1B) on the malignancy of cancers.To explore the influence and mechanism of ASF1B in colorectal cancer (CRC).Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect mRNA expression of ASF1B. Immunohistochemical staining was performed to detect protein expression of ASF1B and Ki67 in tumor tissues. Western blot analysis was used to determine levels of ASF1B and proliferation/epithelial mesenchymal transition (EMT)/stemness-related proteins. In addition, the proliferation of CRC cells was assessed using Cell Counting Kit-8 and 5-Ethynyl-2'-Deoxyuridine assays. The migration and invasion of CRC cells were evaluated using transwell assays. Stemness of CRC cells was tested using the sphere formation assay. To construct a xenograft tumor model, HCT116 cells were introduced into mouse flanksASF1B expression was markedly increased in CRC tissues and cells, and it was inversely correlated with overall survival of CRC patients and was positively associated with the tumor node metastasis (TNM) stage of CRC patients. Silencing of ASF1B suppressed proliferation, migration, invasion, stemness and EMT of CRC cells as well as tumorigenesis of xenograft mice. Furthermore, protein levels of P-phosphatidylinositol 3-kinase (p-PI3K) and p-AKT were decreased after silencing of ASF1B in CRC cells. The inhibitory effects of ASF1B knockdown on cell proliferation, stemness and EMT were partly abolished by PI3K activator in CRC cells.Silencing of ASF1B inactivated the PI3K/AKT pathway to suppress CRC malignancy

A Mg(OtBu)2-catalyzed C(sp3)–H oxidation of α-azido arylethanones to straightforwardly produce primary α-ketoamides is presented.

This study conducted a meta-analysis to compare the effectiveness and safety of the negative pressure wound therapy (NPWT) with the moist wound care (MWC) in the treatment of diabetic foot ulcers (DFUs).The PubMed, EMBASE, and CENTRAL were searched by 2 of the authors, to identify randomized controlled trials comparing the clinical outcomes of patients treated with NPWT versus MWC for DFUs. Meta-analyses were performed for several outcomes, including wound healing results, amputation or resection incidence, and risk of adverse events, utilizing the "meta" package of R language version 4.0.3.A total of 10 trials (619 patients in NPWT group and 625 in MWC group) and 8 trials were included for the qualitative and quantitative syntheses, respectively. As a result, significantly lower risk of non-closure of the wound (risk ratio [RR] = 0.74, 95% confidence interval [CI]: 0.63-0.87; P = .001), lower average wound area (standard mean difference = -0.80, 95% CI: -1.54 to -0.06; P = .034), more wound area decrease (standard mean difference = 0.81, 95% CI: 0.36-1.26; P = .001), increased appearance rate of granulation tissue (RR = 1.61, 95% CI: 1.07-2.41; P-0.021), and lower risk of amputation or resection (RR = 0.70, 95% CI: 0.50-0.99; P = .045), were demonstrated for the NPWT group when compared to MWC group. However, no statistically significant difference was found for the disappearance rate of wound discharge at 8 weeks, the rate of blood culture positivity, VAS-pain score, and the overall frequency of adverse events between the 2 treatment groups (P = .05).NPWT could accelerate process of the wound healing, and decrease the risk of post-treatment amputation or resection, without any additional frequency of adverse events, when compared with MWC, in patients with DFUs.

There is an increasing demand to solve the environmental dissemination problems of fluorosurfactants and improve their responsive behavior, surface properties, chemical stability and foaming performance. In this work, three pH-responsive fluorosurfactants, named F9-es-mor, F9-N3-mor and F9-N2-mor, were synthesized by facile one-step esterification or amidation. The F9-N2-mor efficiently reduced the water surface tension to 14.56 mN·m−1 with a low critical micelle concentration (CMC) of 0.20 mM. More importantly, both F9-N2-mor and F9-N3-mor obviously displayed reproducible pH-response foaming behaviors at an optimal pH of 6.0 and 8.0, respectively, probably owing to their rigid molecular structure, strong intermolecular H-bond and high membrane elasticity. Besides, the morpholine fluorosurfactants defoam at pH below 4.0, indicating that these fluorosurfactants could be recycled and their residue could be easily removed. Overall, the novel fluorosurfactants F9-N2-mor might provide new inspiration to recycle fluorosurfactants as well as construct pH-responsive foams.

Two nonionic Gemini fluorocarbon surfactants containing ecofriendly ester-bonded, named as MN-2C9F19 and EN-2C9F19 were designed and synthesized by one-step esterification. Their surface properties, wettability, thermal properties, and foaming characterization were systematically studied. Two surfactants exhibited high surface activity in aqueous solution, with surface tension (γcmc) of 14.20 mN/m for MN-2C9F19 and 13.71 mN/m for EN-2C9F19. Moreover, MN-2C9F19 and EN-2C9F19 showed high decomposition temperature (Td) of up to 165.4 °C and 176.7 °C respectively. Although the structural difference between methyl and ethyl group is negligible, their wettability and foaming properties are quite different. EN-2C9F19 could wet the low surface energy PTEF plate completely at low concentration (0.6 mM) but MN-2C9F19 needed higher concentration (1.2 mM). Also, EN-2C9F19 exhibited much better foaming property with the foam integrated value F up to 4,370,500 mL·s while MN-2C9F19 could reach up to 2,732,580 mL·s. This maybe ascribe to lower surface tension and higher viscosity of EN-2C9F19 solution. Furthermore, two surfactants showed stronger foaming properties at high temperatures than the conventional foam surfactant SDBS even at room temperature. This work provided an easy synthesis route to develop high-performance foaming agents at high temperatures.

In magnetic resonance imaging (MRI), Gibbs artifact is often introduced by the reconstruction involving only part of the k-space data. The current methods of Gibbs artifact reduction are generally based on the k-space data. In this paper, an image processing method based on inverse diffusion is proposed. This method is directly applied to the MR images, which can achieve the reduction of artifacts while enhancing the edge by the diffusion of pixel gray value. Experiments showed that the Gibbs artifact was effectively reduced and the valuable details of the images were maintained.

A 67-year-old gentleman presented with a 1-day history of left foot pain. He had recently been discharged following a coronary artery bypass graft; during the admission, he had received an intravenous heparin infusion. Examination revealed black-purple discolouration of the first and second digits of the left foot with pitting oedema to the level of the knee. The posterior tibial and dorsalis pedis pulses were both shown to be patent. A new thrombocytopenia was noted. Ultrasound imaging revealed multiple deep vein thrombosis. The history of recent heparin exposure coupled with venous gangrene secondary to deep vein thrombosis was consistent with heparin-induced thrombocytopenia. He was treated acutely with intravenous danaparoid and later with warfarin. There was complete resolution of the venous gangrene at 1 month follow-up.